Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease in a Real-Life Setting: Results From the REPLICA-EPIC18 Study

Destacados, iEpic

JACC Cardiovascular Intervention presentation made at the CRT2023 Congress.

Belen Cid Alvarez, Oriol Rodriguez Leor, Nieves Gonzalo, José Antonio Diarte Miguel, Juan Francisco Muñoz Camacho, Alfonso Jurado Román, Alejandro Diego Nieto, Juan Francisco Oteo, Fernando Rivero, Pablo Avanzas, Iñigo Lozano, Ramon Calviño, Jose Moreu, David Marti Sanchez, Jesus Jimenez Mazuecos, Raymundo Ocaranza-Sanchez, Jose Maria de la Torre, Mohsen Mohandes, Fernando Lozano, Miren Telleria, Jorge Palazuelos, Reyes Gonzalez, Victor Jimenez, Josep Gomez Lara, Armando Perez de Prado.

BACKGROUND

Coronary intravascular lithotripsy (IVL) demonstrated effectiveness in the treatment of calcified lesions in selected patients with stable coronary disease. The purpose of this study is to assess the safety and effectiveness of IVL in calcified coronary lesions in a real- life, all-comers setting.

Link to the study

Comparte este artículo: